NASDAQ : ZJYL

Jin Medical International Ltd. — Financial statements

Healthcare · Medical Instruments & Supplies · China

Last price 2.29 USD (Oct 30, 2026, 3:42 PM EDT) · Market cap 179.61M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Jin Medical International Ltd. (ZJYL) reported revenue of 19.73M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year October - September; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue19.73M20.69M23.50M19.82M19.19M20.76M
Cost of Revenue13.55M14.44M13.89M12.86M12.83M14.18M
Gross Profit6.17M6.24M9.61M6.96M6.36M6.59M
Selling, General & Admin3.84M3.88M4.37M2.37M2.18M2.16M
Research & Development1.78M1.56M1.50M1.54M1.89M1.57M
Other Operating Expenses131.15K198.26K107.08K180.07K159.45K225.06K
Operating Expenses5.75M5.63M5.97M4.10M4.23M3.95M
Operating Income417.94K608.18K3.64M2.87M2.13M2.63M
Interest Expense-9.49K
Interest & Investment Income525.93K789.07K466.52K182.68K181.60K
Currency Exchange Gain (Loss)-278.77K23.07K-26.77K-50.41K186.39K63.35K
Other Non Operating Income (Expenses)597.10K175.49K105.22K222.40K244.12K194.98K
Pretax Income1.26M1.60M4.18M3.22M2.74M2.88M
Income Tax Expense98.96K214.57K763.88K343.71K36.11K248.64K
Earnings From Continuing Operations1.16M1.38M3.42M2.88M2.71M2.63M
Minority Interest in Earnings9.33K-189.95K256.09K
Net Income1.17M1.19M3.68M2.88M2.71M2.63M
Net Income to Common1.17M1.19M3.68M2.88M2.71M2.63M
Shares Outstanding (Basic)7.83M7.83M7.82M7.26M6.75M6.75M
Shares Outstanding (Diluted)7.83M7.83M7.82M7.26M6.75M6.75M
EPS (Basic)0.150.150.470.400.400.39
EPS (Diluted)0.150.150.470.400.400.39
Free Cash Flow-6.96M-3.73M-1.35M2.99M1.54M5.80M
Free Cash Flow Per Share-0.89-0.48-0.170.410.230.86
Gross Margin31.28%30.18%40.89%35.14%33.13%31.72%
Operating Margin2.12%2.94%15.48%14.46%11.10%12.67%
Profit Margin5.95%5.76%15.64%14.52%14.10%12.67%
Free Cash Flow Margin-35.28%-18.01%-5.75%15.10%8.03%27.93%
EBITDA657.35K851.59K3.88M3.09M2.49M2.98M
EBITDA Margin3.33%4.12%16.50%15.60%12.99%14.34%
D&A For EBITDA239.41K243.40K237.82K225.90K362.60K346.61K
EBIT417.94K608.18K3.64M2.87M2.13M2.63M
EBIT Margin2.12%2.94%15.48%14.46%11.10%12.67%
Effective Tax Rate7.84%13.45%18.26%10.67%1.32%8.63%
Revenue as Reported19.73M20.69M23.50M19.82M19.19M20.76M

Balance sheet

Fiscal year October - September; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents9.08M7.46M8.14M6.93M4.79M3.67M
Short-Term Investments21.02M22.17M18.62M9.77M2.28M2.05M
Cash & Short-Term Investments30.10M29.63M26.76M16.70M7.07M5.73M
Accounts Receivable5.51M5.91M8.46M4.23M4.08M4.86M
Other Receivables1.13M888.90K317.31K79.56K167.71K1.11M
Receivables6.65M6.80M8.78M4.31M4.25M5.98M
Inventory6.48M6.95M7.12M5.86M6.88M7.04M
Prepaid Expenses76.20K153.75K165.49K60.00K
Other Current Assets1.25M605.08K4.19M701.40K672.19K
Total Current Assets44.56M44.14M42.82M31.12M18.90M19.42M
Property, Plant & Equipment9.90M7.98M1.72M1.48M1.63M2.11M
Other Intangible Assets1.12M1.10M1.15M154.36K163.21K185.10K
Long-Term Deferred Tax Assets243.70K141.80K121.32K152.47K245.21K182.71K
Other Long-Term Assets13.06K
Total Assets55.84M53.37M45.80M32.90M20.94M21.90M
Accounts Payable2.60M3.26M3.01M3.39M4.11M5.35M
Accrued Expenses449.77K474.08K683.78K326.79K470.96K736.07K
Short-Term Debt17.98M18.84M11.32M4.11M
Current Portion of Leases57.43K72.64K185.15K
Current Income Taxes Payable230.10K259.65K809.39K263.13K170.89K98.11K
Current Unearned Revenue635.11K611.23K797.08K829.22K830.30K1.68M
Other Current Liabilities867.36K284.18K341.96K1.12K118.07K6.38K
Total Current Liabilities22.82M23.80M17.15M8.92M5.70M7.87M
Long-Term Leases96.17K
Total Liabilities25.69M23.80M17.25M8.92M5.70M7.87M
Common Stock7.83K7.83K7.83K7.80K6.75K6.75K
Additional Paid-In Capital6.75M6.75M6.75M6.44M79.81K79.81K
Retained Earnings23.70M23.81M22.61M18.94M16.06M13.35M
Comprehensive Income & Other-135.06K-923.97K-556.21K-1.40M-911.13K588.59K
Total Common Equity30.32M29.64M28.82M23.98M15.24M14.03M
Minority Interest-171.09K-66.25K-262.72K
Shareholders' Equity30.15M29.57M28.55M23.98M15.24M14.03M
Total Liabilities & Equity55.84M53.37M45.80M32.90M20.94M21.90M
Total Debt20.90M18.91M11.60M4.11M
Net Cash (Debt)9.20M10.72M15.15M12.59M7.07M5.73M
Net Cash Per Share1.181.371.941.731.050.85
Filing Date Shares Outstanding78.43M7.83M7.83M7.83M6.75M20.00M
Total Common Shares Outstanding7.83M7.83M7.83M7.80M6.75M20.00M
Working Capital21.73M20.35M25.66M22.19M13.20M11.55M
Book Value Per Share3.873.793.683.082.260.70
Tangible Book Value29.20M28.54M27.67M23.82M15.07M13.84M
Tangible Book Value Per Share3.733.653.533.062.230.69
Buildings2.53M2.45M2.49M2.40M2.46M2.71M
Machinery2.95M2.84M2.74M2.56M2.54M2.76M
Construction In Progress8.54M6.54M
Leasehold Improvements296.66K287.64K363.75K280.88K288.05K317.14K

Cash flow statement

Fiscal year October - September; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income1.17M1.19M3.68M2.88M2.71M2.63M
Depreciation & Amortization311.28K350.68K346.13K225.90K362.60K346.61K
Loss (Gain) From Sale of Assets36.69K36.69K2.59K-6.86K13.37K
Provision & Write-off of Bad Debts98.41K108.78K-47.52K120.33K28.94K-108.71K
Other Operating Activities-428.90K120.38K-264.76K89.60K-86.02K-1.66K
Change in Accounts Receivable302.70K2.27M-3.91M-376.08K333.66K3.08M
Change in Inventory-1.67M168.29K80.31K1.56M-504.39K477.09K
Change in Accounts Payable-602.98K287.04K-499.57K-646.89K-810.34K-369.08K
Change in Unearned Revenue144.26K-171.32K-63.76K20.25K-755.37K647.86K
Change in Income Taxes-300.86K-793.62K820.02K30.52K155.50K-95.34K
Change in Other Net Operating Assets348.54K-669.13K-1.35M-784.06K149.56K-776.27K
Operating Cash Flow-592.87K2.90M-1.21M3.11M1.58M5.84M
Capital Expenditures-6.37M-6.63M-144.95K-113.94K-40.17K-42.88K
Sale of Property, Plant & Equipment444.00444.00348.0010.14K
Cash Acquisitions-500.00K
Sale (Purchase) of Intangibles-979.28K
Investment in Securities-15.12K-3.66M-8.39M-7.63M-445.17K-809.73K
Other Investing Activities364.43K-215.03K
Investing Cash Flow-6.38M-10.79M-9.51M-7.73M-120.90K-1.07M
Short-Term Debt Issued19.02M16.90M5.67M121.86K768.00K
Total Debt Issued26.62M19.02M16.90M5.67M121.86K768.00K
Short-Term Debt Repaid-11.57M-5.56M-5.89M-3.64M
Total Debt Repaid-21.97M-11.57M-5.56M-5.89M-3.64M
Net Debt Issued (Repaid)4.65M7.46M11.34M-213.24K121.86K-2.87M
Issuance of Common Stock312.00K8.34M
Other Financing Activities-103.74K-103.74K-1.21M
Financing Cash Flow4.54M7.35M11.65M6.91M121.86K-2.87M
Foreign Exchange Rate Adjustments382.52K-139.64K273.63K-149.90K-461.24K103.30K
Net Cash Flow-2.05M-674.55K1.21M2.14M1.12M2.01M
Free Cash Flow-6.96M-3.73M-1.35M2.99M1.54M5.80M
Free Cash Flow Margin-35.28%-18.01%-5.75%15.10%8.03%27.93%
Free Cash Flow Per Share-0.89-0.48-0.170.410.230.86
Levered Free Cash Flow-7.49M-5.11M688.00K-1.57M1.34M4.07M
Unlevered Free Cash Flow-7.49M-5.11M688.00K-1.57M1.34M4.08M
Cash Interest Paid526.31K411.07K239.37K5.32K68.78K
Cash Income Tax Paid570.30K564.79K205.37K142.73K13.82K302.25K
Change in Working Capital-1.78M1.10M-4.92M-200.81K-1.43M2.96M

Ratios

Fiscal year October - September; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization184.32M88.45M421.11M182.46M
Enterprise Value175.12M73.25M404.98M170.53M
Last Close Price2.3511.3053.8023.40
PE Ratio15.6974.25114.5663.39
PS Ratio9.344.2817.929.21
PB Ratio0.612.9914.757.61
P/TBV Ratio6.313.1015.227.66
P/FCF Ratio60.97
P/OCF Ratio30.4658.74
EV/Sales Ratio8.883.5417.238.60
EV/EBITDA Ratio266.4086.02104.4755.13
EV/EBIT Ratio419.00120.44111.3059.48
EV/FCF Ratio56.99
Debt / Equity Ratio0.690.640.410.17
Debt / EBITDA Ratio23.8817.662.831.33
Debt / FCF Ratio1.37
Net Debt / Equity Ratio-0.30-0.36-0.53-0.53-0.46-0.41
Net Debt / EBITDA Ratio-14.00-12.59-3.91-4.07-2.83-1.92
Net Debt / FCF Ratio1.322.8811.21-4.21-4.59-0.99
Asset Turnover0.380.420.600.740.900.97
Inventory Turnover2.162.052.142.021.841.98
Quick Ratio1.611.532.072.351.991.49
Current Ratio1.951.852.503.493.312.47
Return on Equity (ROE)4.02%4.75%13.02%14.68%18.50%21.20%
Return on Assets (ROA)0.50%0.77%5.78%6.66%6.22%7.70%
Return on Invested Capital (ROIC)1.84%3.26%23.99%26.19%25.53%25.43%
Return on Capital Employed (ROCE)1.30%2.10%12.70%12.00%14.00%18.80%
Earnings Yield6.37%1.35%0.87%1.58%
FCF Yield-3.78%-4.21%-0.32%1.64%
Buyback Yield / Dilution-0.05%-7.81%-7.51%66.25%